Variations of alpha 2-plasmin inhibitor, antithrombin III, plasminogen in the serum of patients of cerebral thrombosis infused with urokinase.
作者信息
Takada A, Takada Y, Uemura K, Nakajima S, Ryu H, Ninchoji T
出版信息
Thromb Res. 1979;15(5-6):889-94. doi: 10.1016/0049-3848(79)90198-1.
PMID:115108
Abstract
摘要
相似文献
1
Variations of alpha 2-plasmin inhibitor, antithrombin III, plasminogen in the serum of patients of cerebral thrombosis infused with urokinase.输注尿激酶的脑血栓患者血清中α2-纤溶酶抑制剂、抗凝血酶III、纤溶酶原的变化
Thromb Res. 1979;15(5-6):889-94. doi: 10.1016/0049-3848(79)90198-1.
2
Plasmin inhibitors in different fibrinolytic treatment patterns.不同纤维蛋白溶解治疗模式中的纤溶酶抑制剂
Haemostasis. 1981;10(1):51-62. doi: 10.1159/000214386.
3
Retrospective study on the efficacy of using urokinase therapy.尿激酶治疗效果的回顾性研究。
Nihon Ketsueki Gakkai Zasshi. 1979 Aug;42(4):684-8.
4
[Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
Nihon Naika Gakkai Zasshi. 1979 May 10;68(5):486-9.
5
Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.硫酸葡聚糖在尿激酶治疗中的作用以及通过纤溶酶抑制剂、纤维蛋白原降解产物和纤溶降解产物的评估来评价疗效
Jpn Heart J. 1982 May;23(3):339-47. doi: 10.1536/ihj.23.339.
6
7
8
[Urokinase. Biochemical therapeutical and therapeutical data (author's transl)].[尿激酶。生化治疗及治疗数据（作者译）]
Pathol Biol (Paris). 1976 Dec;24 Suppl:54-69.
9
The thrombolytic effect of lumbrokinase is not as potent as urokinase in a rabbit cerebral embolism model.在兔脑栓塞模型中，蚓激酶的溶栓效果不如尿激酶显著。
J Korean Med Sci. 1993 Apr;8(2):117-20. doi: 10.3346/jkms.1993.8.2.117.
10
Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.以原发性或继发性纤维蛋白溶解为特征的出血性疾病中的纤溶酶-α2-抗纤溶酶复合物。
Br J Haematol. 1984 Apr;56(4):545-56. doi: 10.1111/j.1365-2141.1984.tb02179.x.
Zotero 插件